Creates substance use prevention and recovery resource materials which include age-appropriate information on the risks of drug use, overdoses, fentanyl, including its high potency, the severe risks associated with its use, the prevalence of counterfeit pills containing fentanyl, and the concept of fentanyl poisoning, and how to include resources from outside of the school district to improve instruction.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Relates to prohibiting supervised injection sites; provides that it shall be unlawful for any person to own, operate, work in or volunteer at a supervised injection site; defines terms and establishes penalties.
This bill creates a certification process for entities providing in-home substance use disorder treatment services in New York. It requires applicants to meet specific clinical standards, including conducting screenings for overdose risk, mental health conditions, and problem gambling, developing safety plans, and providing medication-assisted treatment and naloxone. Applicants must also submit a needs assessment and service proposal, with one required consultation meeting with local governments. The certification process must be established within six months, directly affecting treatment providers seeking to offer these services statewide.
This bill requires state agencies managing the opioid stewardship fund to submit quarterly reports detailing fund activity. The reports must include the total funds held, amounts paid out each quarter, and the names and locations of all organizations receiving funds (awards) and providing funds (receipts). These reports are sent to the opioid settlement board, state legislative leaders, and relevant committees, aiming to increase transparency in how opioid settlement funds are distributed and managed. The requirement applies directly to the Office of Addiction Services and the Department of Health.
Directs the state comptroller to conduct an audit of the department of health and other agencies to ensure that the agency meets its responsibilities to review and assess Medicaid managed care organizations for compliance with federal and state requirements to maintain adequate health care providers within network, and to meet mental health and substance use disorder parity requirements.
This bill (S 1580) requires state human services agencies to implement a 7.8% cost-of-living adjustment (COLA) for eligible programs starting April 1, 2025. It directly affects programs administered by the Office of Mental Health, Office for People with Developmental Disabilities, and Office of Addiction Services and Supports, including mental health clinics, developmental disability services, and addiction treatment programs. The COLA applies to reimbursement rates for these services and mandates that recipients use funds to provide at least a 2.6% targeted salary increase for eligible staff. The bill prohibits other new COLA increases during this period, except for specific federal pandemic relief programs.
Establishes a regional or county-based peer support services program for transgender and non-binary individuals that provides support services including but not limited to, peer counseling for mental illness including alcohol and substance abuse counseling, family support services, domestic violence, mental health and physical health.
Requires the office of mental health, office of addiction services and supports and the department of education to create a behavioral health website which shall provide information on various behavioral health issues such as depression, eating disorders, anxiety, schizophrenia, post-traumatic stress disorder and bipolar disorder.
This bill prohibits cannabis retail stores and on-site consumption licenses from being located within 200 feet of an "addiction treatment center" as defined by the law. An addiction treatment center is specifically defined as a licensed or certified facility providing clinical treatment for substance use disorders, mental illness, or chemical dependence (excluding peer support groups or non-clinical gatherings). The law applies to all cannabis retail licensees and applicants, requiring them to avoid locations near these treatment centers, similar to existing 500-foot buffers around schools. This policy directly affects cannabis businesses seeking new locations or licenses within the specified proximity.
